| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.6M | -6.0% |
| Cost of Revenue | $4.5M | +1.5% |
| Gross Profit | $1.2M | -26.7% |
| R&D Expense | $295K | -25.7% |
| SG&A Expense | $7.9M | -9.6% |
| Operating Income | -$6.8M | +5.8% |
| Pre-tax Income | -$13.5M | -80.9% |
| Income Tax | -$2K | -147.0% |
| Net Income | -$13.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $548K | -86.1% |
| Accounts Receivable | $613K | +295.7% |
| Inventory | $4.8M | +26.3% |
| Current Assets | $7.8M | -5.1% |
| Total Assets | $9.1M | -23.5% |
| Current Liabilities | $5.8M | +45.6% |
| Long-term Debt | $230K | -34.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.6M | -72.9% |
| Investing Cash Flow | $113K | +584.1% |
| Financing Cash Flow | $6.1M | +170.0% |
| -80.8% |
| EPS (Basic) | -$21.03 | +80.6% |
| EPS (Diluted) | -$21.03 | +80.6% |
| Total Liabilities |
| $6.6M |
| +0.5% |
| Stockholders' Equity | $2.5M | -52.9% |